Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia
Steven B. Heymsfield, Nicole M. Avena, Leslie J. Baier, et al.
Obesity (2014) Vol. 22, Iss. S1
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity
Sarah Hampl, Sandra G. Hassink, Asheley Cockrell Skinner, et al.
PEDIATRICS (2023) Vol. 151, Iss. 2
Closed Access | Times Cited: 645
Lifestyle modification approaches for the treatment of obesity in adults.
Thomas A. Wadden, Jena Shaw Tronieri, Meghan L. Butryn
American Psychologist (2020) Vol. 75, Iss. 2, pp. 235-251
Open Access | Times Cited: 401
Physiological adaptations to weight loss and factors favouring weight regain
Frank L. Greenway
International Journal of Obesity (2015) Vol. 39, Iss. 8, pp. 1188-1196
Open Access | Times Cited: 361
Cardiometabolic risk in obese children
Stephanie T. Chung, Anthony Onuzuruike, Sheela N. Magge
Annals of the New York Academy of Sciences (2018) Vol. 1411, Iss. 1, pp. 166-183
Open Access | Times Cited: 179
Complexity and Stigma of Pediatric Obesity
Andrea M. Haqq, Maryam Kebbe, Qiming Tan, et al.
Childhood Obesity (2021) Vol. 17, Iss. 4, pp. 229-240
Open Access | Times Cited: 110
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea M. Haqq, Wendy K. Chung, Hélène Dollfus, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 12, pp. 859-868
Open Access | Times Cited: 99
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
Anke Hinney, Antje Körner, Pamela Fischer‐Posovszky
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 623-637
Open Access | Times Cited: 76
Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes
Louisa Kalsner, Stormy J. Chamberlain
Pediatric Clinics of North America (2015) Vol. 62, Iss. 3, pp. 587-606
Open Access | Times Cited: 138
New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma
Hermann L. Müller, Thomas E. Merchant, Stéphanie Puget, et al.
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 5, pp. 299-312
Open Access | Times Cited: 134
Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review
Laura van Iersel, Karen E Brokke, Roger A.H. Adan, et al.
Endocrine Reviews (2018) Vol. 40, Iss. 1, pp. 193-235
Open Access | Times Cited: 112
Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
Robert Haws, Sheila M. Brady, Elisabeth K. Davis, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 11, pp. 2133-2140
Open Access | Times Cited: 103
Evolutionary and neuropsychological perspectives on addictive behaviors and addictive substances: relevance to the "food addiction" construct
Caroline Davis
Substance Abuse and Rehabilitation (2014), pp. 129-129
Open Access | Times Cited: 97
Craniopharyngioma and hypothalamic injury
Hermann L. Müller
Current Opinion in Endocrinology Diabetes and Obesity (2015) Vol. 23, Iss. 1, pp. 81-89
Open Access | Times Cited: 94
Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
Chong Kun Cheon
Annals of Pediatric Endocrinology & Metabolism (2016) Vol. 21, Iss. 3, pp. 126-126
Open Access | Times Cited: 93
Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview
Arnab Banerjee, Sandip Mukherjee, Bithin Kumar Maji
Toxicology Reports (2021) Vol. 8, pp. 938-961
Open Access | Times Cited: 78
Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
Lauren Schwartz, Assumpta Caixàs, Anastasia Dimitropoulos, et al.
Journal of Neurodevelopmental Disorders (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review
Qiming Tan, Camila E. Orsso, Edward C. Deehan, et al.
Obesity Reviews (2019) Vol. 21, Iss. 5
Closed Access | Times Cited: 71
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention
Christian Roth
Journal of Clinical Medicine (2015) Vol. 4, Iss. 9, pp. 1774-1797
Open Access | Times Cited: 70
Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center
Lotte Kleinendorst, Ozair Abawi, Bibian van der Voorn, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232990-e0232990
Open Access | Times Cited: 44
Seaweeds’ nutraceutical and biomedical potential in cancer therapy: a concise review
João Cotas, Diana Pacheco, Ana M. M. Gonçalves, et al.
Journal of Cancer Metastasis and Treatment (2021) Vol. 2021
Open Access | Times Cited: 40
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design
Robert Haws, Gregory Gordon, Joan C. Han, et al.
Contemporary Clinical Trials Communications (2021) Vol. 22, pp. 100780-100780
Open Access | Times Cited: 37
Vaporized Δ9-THC in utero results in reduced birthweight, increased locomotion, and altered wake-cycle activity dependent on dose, sex, and diet in the offspring
Nicole Roeder, Samantha L. Penman, Brittany Richardson, et al.
Life Sciences (2024) Vol. 340, pp. 122447-122447
Closed Access | Times Cited: 5
The role of glucagon‐like peptide 1 receptor agonists for weight control in individuals with acquired hypothalamic obesity—A systematic review
Victoria Wen Wei Ng, Gheslynn Gerard, Jonathan Jin Kai Koh, et al.
Clinical Obesity (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 5
Differentiating monogenic and syndromic obesities from polygenic obesity: Assessment, diagnosis, and management
Angela Fitch, Sonali Malhotra, Rushika Conroy
Obesity Pillars (2024) Vol. 11, pp. 100110-100110
Open Access | Times Cited: 5
Eating behavior patterns, metabolic parameters and circulating oxytocin levels in patients with obesity: an exploratory study
Colonnello Elena, Libotte Flavia, Masi Davide, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2025) Vol. 30, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top